unknown
Stage
1
Investors
About
Hillstar Bio is pioneering precision immunotherapies that target and deplete pathogenic immune cells, aiming to reset the immune system and transform treatment for autoimmune diseases.
Explore Hillstar Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.